122 related articles for article (PubMed ID: 10779632)
21. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma.
Lawson EA; Zhang X; Crocker JT; Wang WL; Klibanski A
J Clin Endocrinol Metab; 2009 Jul; 94(7):2226-31. PubMed ID: 19383775
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma.
Pavelić J; Radaković B; Pavelić K
Gynecol Oncol; 2007 Jun; 105(3):727-35. PubMed ID: 17399767
[TBL] [Abstract][Full Text] [Related]
23. Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system.
Hu JF; Vu TH; Hoffman AR
Mol Endocrinol; 1995 May; 9(5):628-36. PubMed ID: 7565809
[TBL] [Abstract][Full Text] [Related]
24. Biallelic expression of all four IGF-II promoters and its association with increased methylation of H19 gene in human brain.
Zhan S; Zhang L; Van M; Young C; Helman LJ
Brain Res; 1998 May; 792(2):283-90. PubMed ID: 9593943
[TBL] [Abstract][Full Text] [Related]
25. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
26. Expression of messenger RNAs encoding insulin-like growth factor-I, -II, and insulin-like growth factor binding protein-2 in bovine endometrium during the estrous cycle and early pregnancy.
Geisert RD; Lee CY; Simmen FA; Zavy MT; Fliss AE; Bazer FW; Simmen RC
Biol Reprod; 1991 Dec; 45(6):975-83. PubMed ID: 1725270
[TBL] [Abstract][Full Text] [Related]
27. Elevation of insulin-like growth factor-binding protein-1 mRNA expression following hormone replacement therapy.
Wang HS; Wang TH; Soong YK
Hum Reprod; 2000 Jan; 15(1):50-4. PubMed ID: 10611187
[TBL] [Abstract][Full Text] [Related]
28. Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization.
Gallagher EM; O'Shea DM; Fitzpatrick P; Harrison M; Gilmartin B; Watson JA; Clarke T; Leonard MO; McGoldrick A; Meehan M; Watson C; Furlong F; O'Kelly P; Fitzpatrick JM; Dervan PA; O'Grady A; Kay EW; McCann A
Clin Cancer Res; 2008 Nov; 14(21):6829-38. PubMed ID: 18980977
[TBL] [Abstract][Full Text] [Related]
29. Endometrial expression of leptin receptor and members of the growth hormone-Insulin-like growth factor system throughout the estrous cycle in heifers.
Sosa C; Carriquiry M; Chalar C; Crespi D; Sanguinetti C; Cavestany D; Meikle A
Anim Reprod Sci; 2010 Dec; 122(3-4):208-14. PubMed ID: 20950968
[TBL] [Abstract][Full Text] [Related]
30. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
31. Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors.
Rutanen EM; Nyman T; Lehtovirta P; Ammälä M; Pekonen F
Int J Cancer; 1994 Nov; 59(3):307-12. PubMed ID: 7523316
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.
Küffer S; Gutting T; Belharazem D; Sauer C; Michel MS; Marx A; Trojan L; Ströbel P
Mol Oncol; 2018 Feb; 12(2):256-266. PubMed ID: 29239100
[TBL] [Abstract][Full Text] [Related]
33. [Insulin-like growth factor 2 imprinting status and promoter usage in the placenta of macrosomia].
Yao JC; Hu YL; Wang ZQ; Dai YM; Ling JX; Ye XD
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):309-14. PubMed ID: 17673042
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.
McCampbell AS; Broaddus RR; Loose DS; Davies PJ
Clin Cancer Res; 2006 Nov; 12(21):6373-8. PubMed ID: 17085648
[TBL] [Abstract][Full Text] [Related]
36. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women.
Woodson K; Flood A; Green L; Tangrea JA; Hanson J; Cash B; Schatzkin A; Schoenfeld P
J Natl Cancer Inst; 2004 Mar; 96(5):407-10. PubMed ID: 14996863
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-I expression in normal and diseased endometrium.
Maiorano E; Loverro G; Viale G; Giannini T; Napoli A; Perlino E
Int J Cancer; 1999 Jan; 80(2):188-93. PubMed ID: 9935198
[TBL] [Abstract][Full Text] [Related]
38. Progestin and antiprogestin differentially regulate the expression of insulin-like growth factors (IGF-I and IGF-II) messenger ribonucleic acid in human endometrial stromal cells.
Gao JG; Zhu HH; Fan J; Mazella J; Tseng L
Biol Reprod; 1995 Aug; 53(2):355-60. PubMed ID: 7492687
[TBL] [Abstract][Full Text] [Related]
39. Expression of TGF-beta type I and II receptors in normal and cancerous human endometrium.
Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Jakowicki JA; Krajewska WM
Cancer Lett; 2002 Dec; 186(2):231-9. PubMed ID: 12213293
[TBL] [Abstract][Full Text] [Related]
40. Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.
Kaneda A; Wang CJ; Cheong R; Timp W; Onyango P; Wen B; Iacobuzio-Donahue CA; Ohlsson R; Andraos R; Pearson MA; Sharov AA; Longo DL; Ko MS; Levchenko A; Feinberg AP
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20926-31. PubMed ID: 18087038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
